HIV clinical trials Pharmacologist
Gene Morse, Pharm D, admits his green thumb needs a little bit of work.
“The tomatoes and peppers are the happiest vegetables in the garden while the beans and eggplants never quite get the start they need each spring, ” he says.
One of the reasons Morse cannot give his garden his full attention is because he travels to Zimbabwe once or twice a year. Morse is the Director of the AIDS Clinical Trials Group (ACTG) Network’s Clinical Pharmacology Core and chairs the ACTG Clinical Pharmacology Advisory Group. Morse is the Principal Investigator for the University of Buffalo (UB) Pharmacology Specialty Laboratory (PSL) and a Co-Investigator of the University of Rochester Clinical Trials Unit. Morse and his staff have a separate National Institute of Allergy and Infectious Diseases (NIAID) contract to provide a global HIV clinical pharmacology quality assurance program that includes pharmacokinetics research methods training to the ACTG’s 60 sites around the world as well as all of the other NIAID HIV research networks and PSLs. They also support a National Institutes of Health (NIH) Fogarty International Center AIDS International Training and Research Program with the University of Zimbabwe (UZ). The grants and contracts UB holds under Morse’s direction led to his receiving the Volweiler award. The award is a nationally recognized honor from the American Association of Colleges of Pharmacy.
“We travel to Zimbabwe and their faculty, fellows and staff travel to the United States to ensure the UZ pharmacology lab they have developed runs smoothly. The lab is three years old now and is gearing up to assay samples from ACTG studies, ” Morse says. “During my first trip to Zimbabwe, I spoke at a community center to 600 people about the ACTG’s research studies and the importance of participation. When I first started my career, I never would have dreamed I would be talking in Africa about research and contributing to the global effort against HIV/AIDS. That moment in Africa and receiving the Volweiler award reaffirmed my goals and professional path toward contributing to the global HIV epidemic and trying to have an impact on reaching an AIDS-free generation.”
Charles Maponga, PharmD, is the Director of the Pharmacology Specialty Laboratory at the ACTG’s University of Zimbabwe Parirenyatwa site.
“Gene Morse has an extraordinary ability to articulate new ideas, ” Maponga says. “He is the most generous American I have ever met.”
Morse was one of the original investigators and laboratory directors when the ACTG was formed in 1987 and has been with the Network ever since. He completed a research fellowship at UB in New York in 1984.
The Patients Voice in HIV/AIDS Clinical Trial Participation: What motivates the willingness of HIV infected people to take part in HIV/AIDS clinical trials?
Book (LAP LAMBERT Academic Publishing)
BMC Medical Research Methodology at the 35th Annual Conference of the .. — BMC Pediatrics
The conference will focus on issues such as design and analysis of clinical trials, methods in biostatistics and development of clinical prediction models.